01.12.2014 11:43:37
|
Sunshine: Austria Site For OPTIONS-HF Study Implants Patient With C-Pulse System
(RTTNews) - Sunshine Heart, Inc. (SHC.AX, SSH) said its initial Austrian site for the OPTIONS-HF study has implanted its first patient with the C-Pulse System for moderate to severe heart failure.
Prof. Dr. Herwig Antretter of the University of Innsbruck performed the operation, which took place on November 11.
A 92-minute surgical implantation procedure was successfully completed and the patient was discharged from the hospital 7 days after surgery.
The patient suffers from dilated cardiomyopathy with severe impairment of his left ventricle, low ejection fraction and has survived an extensive cardiopulmonary resuscitation due to sudden cardiac arrest in January without any neurological deficit.
Despite his advanced age and his medical history, the patient remains highly active and employed.
Sunshine said this milestone marks the eleventh implantation of the C-Pulse System across fourteen activated EU centers participating in the OPTIONS HF post-market surveillance clinical study.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sunshine Heart Incmehr Nachrichten
Keine Nachrichten verfügbar. |